Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag

P. Felicetti, M. Mennecozzi, A. Barucca, S. Montgomery, F. Orlandi, K. Manova, A. N. Houghton, P. D. Gregor, A. Concetti, F. M. Venanzi

Research output: Contribution to journalArticlepeer-review


Background We have previously shown that xenogeneic DNA vaccines encoding rat neu and melanosomal differentiation Ag induce tumor immunity. Others have developed vaccines targeting tumor neovasculature. Tumor endothelial marker 8 (TEM8) is expressed in the neovasculature of human tumors, and in the mouse melanoma B16, but its expression is limited in normal adult tissues. We describe a DNA vaccine combining xenogeneic tumor Ag and TEM8. Methods In-situ hybridization was used to detect TEM8 RNA in mouse tumors. Mice transgenic for the rat neu proto-oncogene were immunized with DNA vaccines encoding TEM8 and the extracellular domain of rat neu and challenged with the 233-VSGA1 breast cancer cell line. In parallel experiments, C57BL/6 mice were immunized with TEM8 and human tyrosinase-related protein 1 (hTYRP1/hgp75) and challenged with B16F10 melanoma. Results TEM8 was expressed in the stroma of transplantable mouse breast and melanoma tumors. In both model systems, TEM8 DNA had no activity as a single agent but significantly enhanced the anti-tumor immunity of neu and hTYRP1/hgp75 DNA vaccines when given in concert. The observed synergy was dependent upon CD8-T cells, as depletion of this cell population just prior to tumor challenge obviated the effect of the TEM8 vaccine in both tumor models. Discussion A local immune response to TEM8 may increase inflammation or tumor necrosis within the tumor, resulting in improved Ag presentation of HER2/neu and hTYRP1/hgp75. Alternatively, TEM8 expression in host APC may alter T-cell interactions or homing. In this way, TEM8 may act more as an adjuvant than an immunologic target.

Original languageEnglish
Pages (from-to)23-34
Number of pages12
Issue number1
Publication statusPublished - 2007


  • Breast cancer
  • DNA vaccine
  • Melanoma
  • Neovasculature
  • Tumor immunology.

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag'. Together they form a unique fingerprint.

Cite this